Globe Life (NYSE:GL) Given New $171.00 Price Target at Wells Fargo & Company

Globe Life (NYSE:GL) had its price objective hoisted by analysts at Wells Fargo & Company from $170.00 to $171.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 20.53% from the company’s current price.

Other equities research analysts have also issued reports about the stock. Truist Financial lifted their target price on shares of Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, February 6th. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. JPMorgan Chase & Co. increased their target price on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Evercore set a $157.00 price target on Globe Life in a research note on Wednesday, February 18th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus target price of $171.33.

Globe Life Price Performance

NYSE:GL traded down $0.41 during trading hours on Wednesday, hitting $141.88. 44,831 shares of the company’s stock traded hands, compared to its average volume of 502,317. Globe Life has a 52 week low of $109.38 and a 52 week high of $152.71. The business’s fifty day simple moving average is $141.50 and its two-hundred day simple moving average is $138.60. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The firm has a market cap of $11.29 billion, a P/E ratio of 10.05 and a beta of 0.47.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the business earned $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, research analysts anticipate that Globe Life will post 13.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Globe Life

In other news, Director Mark A. Blinn sold 1,750 shares of the firm’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the transaction, the director directly owned 3,372 shares of the company’s stock, valued at approximately $498,752.52. This trade represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $143.14, for a total value of $1,431,400.00. Following the completion of the sale, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at approximately $2,501,944.06. This trade represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 63,629 shares of company stock valued at $9,223,785. Corporate insiders own 1.97% of the company’s stock.

Institutional Trading of Globe Life

A number of institutional investors have recently made changes to their positions in GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after buying an additional 607 shares during the period. NewEdge Advisors LLC boosted its position in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after buying an additional 5,352 shares during the period. Goldman Sachs Group Inc. grew its holdings in Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after acquiring an additional 58,163 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of Globe Life in the first quarter valued at about $428,000. Finally, Focus Partners Wealth raised its stake in shares of Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after acquiring an additional 656 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.